Raymond James Financial Services Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Raymond James Financial Services Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-18,200	Closed	-$12K	–	3426
2021 Q2	$12K	Buy	18,200 +2,000	+12%	+$263K	﹤0.01%	3271
2021 Q1	$3K	Buy	+16,200	New	+$2.43M	﹤0.01%	3171
2020 Q3	–	Sell	-17,600	Closed	-$3K	–	3004
2020 Q2	$3K	Sell	17,600 -3,800	-18%	-$374K	﹤0.01%	2810
2020 Q1	$3K	Buy	+21,400	New	+$1.89M	﹤0.01%	2414
2019 Q3	–	Sell	-21,600	Closed	-$10K	–	2935
2019 Q2	$10K	Sell	21,600 -100	-0.5%	-$8.53K	﹤0.01%	2822
2019 Q1	$2K	Buy	+21,700	New	+$1.85M	﹤0.01%	2791
2018 Q3	–	Sell	-22,300	Closed	-$1K	–	2897
2018 Q2	$1K	Buy	+22,300	New	+$2.05M	﹤0.01%	2773

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Raymond James Financial Services Advisors's XBI Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 25% in Q3 2024, selling an estimated $6.97M and leaving 215,084 shares worth $21.3M. The position accounts for 0.03% of the portfolio, ranked #525.

Raymond James Financial Services Advisors first reported a position in XBI in Q3 2015 and has held it in 37 quarters since. The position peaked at $36.9M in Q2 2021. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

Raymond James Financial Services Advisors held 215,084 shares of State Street SPDR S&P Biotech ETF worth $21.3M as of Q3 2024.
Raymond James Financial Services Advisors sold 70,955 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $6.97M.
State Street SPDR S&P Biotech ETF made up 0.03% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #525 holding.
Raymond James Financial Services Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and has held it in 37 quarters since.
Raymond James Financial Services Advisors's State Street SPDR S&P Biotech ETF position peaked at $36.9M in Q2 2021.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.